SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-014868
Filing Date
2022-08-04
Accepted
2022-08-04 17:12:24
Documents
60
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q nuvb-20220630.htm   iXBRL 10-Q 3211505
2 EX-31.1 nuvb-ex31_1.htm EX-31.1 21168
3 EX-31.2 nuvb-ex31_2.htm EX-31.2 21268
4 EX-32.1 nuvb-ex32_1.htm EX-32.1 11236
5 EX-32.2 nuvb-ex32_2.htm EX-32.2 9586
  Complete submission text file 0000950170-22-014868.txt   10909034

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT nuvb-20220630_def.xml EX-101.DEF 174641
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT nuvb-20220630_cal.xml EX-101.CAL 50530
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT nuvb-20220630.xsd EX-101.SCH 50673
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT nuvb-20220630_lab.xml EX-101.LAB 395118
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT nuvb-20220630_pre.xml EX-101.PRE 298559
54 EXTRACTED XBRL INSTANCE DOCUMENT nuvb-20220630_htm.xml XML 2532945
Mailing Address 357 TEHAMA STREET, FLOOR 3 SAN FRANCISCO CA 94103
Business Address 357 TEHAMA STREET, FLOOR 3 SAN FRANCISCO CA 94103 (415) 754-3517
Nuvation Bio Inc. (Filer) CIK: 0001811063 (see all company filings)

IRS No.: 850862255 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39351 | Film No.: 221137706
SIC: 2834 Pharmaceutical Preparations